CoreAge Rx vs Auren Rx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Auren Rx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 79 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
That doesn't make Auren Rx a bad call — it's best for shoppers who want the no-commitment monthly rate and the subscription rate printed side by side. Weigh the six factors below against your own priorities before you decide.
Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| CoreAge Rx | Auren Rx | |
|---|---|---|
| Brief Score | 94/100 (A) | 79/100 (C) |
| Semaglutide | $99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published | From $179/mo (compounded) |
| Tirzepatide | $149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published | From $179/mo (compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.
Auren Rx: New to the tracker on 1 September 2026, and read on the provider's own site rather than taken on trust: we checked https://www.aurenrx.com/ on 2026-09-01 and this row reflects what those pages say. The line we publish is the no-commitment rate, From $179/mo (compounded), because that is what a reader who has committed to nothing actually pays. Semaglutide and tirzepatide are one price here and the molecule selector does not change it, which we checked by clicking it. Our two August records of this provider disagree with each other about the earlier rate, so we are not claiming a price movement we cannot stand behind.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.